Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-08 Sale | 2021-07-09 5:08 pm | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 100,000 | $4.29 | $429,000 | 467,577 (Direct) | View |
| 2021-03-11 Sale | 2021-03-12 7:04 pm | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 50,000 | $4.28 | $214,000 | 224,406 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-24 Disposition | 2022-05-26 5:30 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director | 167,817 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:30 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director | 641,708 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:28 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 467,577 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:28 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 621,708 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:27 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Richardson Peter C See Remarks | 50,613 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:27 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Richardson Peter C See Remarks | 128,216 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Smith Karen L. Director | 79,645 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Smith Karen L. Director | 173,517 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 170,575 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 1,147,882 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:25 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J See Remarks | 740,843 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:25 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J See Remarks | 1,321,433 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:24 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 249,858 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:24 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 471,708 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:24 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 915,270 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:24 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 1,144,881 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:23 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President and CEO | 2,862,459 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:23 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President and CEO | 4,276,374 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:23 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Volkart Carmen B Director | 55,916 | $0 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:22 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 79,645 | $5.6 | 0 (Direct) | View |
| 2022-05-24 Disposition | 2022-05-26 5:22 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 173,517 | $0 | 0 (Direct) | View |
| 2022-03-03 Tax Withholding | 2022-03-04 6:38 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 37,695 | $3.8 | 2,488,360 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-04 6:38 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 86,814 | $0 | 2,488,360 (Direct) | View |
| 2022-03-03 Tax Withholding | 2022-03-04 6:36 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 11,506 | $3.8 | 791,036 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-04 6:36 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 27,780 | $0 | 791,036 (Direct) | View |
| 2022-03-03 Tax Withholding | 2022-03-04 6:34 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 13,635 | $3.8 | 616,609 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-04 6:34 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 26,044 | $0 | 616,609 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 7:19 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 13,299 | $3.66 | 604,200 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 7:19 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 23,068 | $0 | 604,200 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 7:16 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 11,496 | $3.66 | 774,762 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 7:16 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 24,606 | $0 | 774,762 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 7:13 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 34,282 | $3.66 | 2,439,241 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 7:13 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 76,893 | $0 | 2,439,241 (Direct) | View |
| 2021-10-26 Ownership | 2022-02-04 7:09 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 125,000 | $0 | 170,575 (Direct) | View |
| 2021-10-27 Option Award | 2021-10-29 6:14 pm | 2022-10-27 2031-10-27 | ANTARES PHARMA INC. | ATRS | Volkart Carmen B Director | 55,916 | $0 | 55,916 (Direct) | View |
| 2021-08-27 Option Award | 2021-08-31 6:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 24,679 | $2.24 | 295,575 (Direct) | View |
| 2021-08-27 Exercise | 2021-08-31 6:26 pm | 2021-08-27 2021-09-08 | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 24,679 | $0 | 295,575 (Direct) | View |
| 2021-08-27 Tax Withholding | 2021-08-31 6:26 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 13,820 | $4 | 295,575 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:27 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Smith Karen L. Director | 25,452 | $4.42 | 128,187 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:27 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | Smith Karen L. Director | 48,542 | $0 | 128,187 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:25 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director | 25,452 | $4.42 | 216,359 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:25 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | ROCHE ROBERT P JR Director | 48,542 | $0 | 216,359 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:25 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer | 36,199 | $4.42 | 105,236 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:25 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer | 69,037 | $0 | 105,236 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:24 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 85,973 | $4.42 | 925,615 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:24 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 163,963 | $0 | 925,615 (Direct) | View |
| 2021-06-13 Tax Withholding | 2021-06-14 6:24 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 29,207 | $4.45 | 925,615 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:24 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 31,674 | $4.42 | 345,123 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:24 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | JACOB LEONARD S Director | 60,407 | $0 | 345,123 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:23 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 25,452 | $4.42 | 616,119 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:23 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 48,542 | $0 | 616,119 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:22 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 25,452 | $4.42 | 128,187 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:22 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | Greenleaf Peter Director | 48,542 | $0 | 128,187 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:21 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 85,973 | $4.42 | 758,394 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:21 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 163,963 | $0 | 758,394 (Direct) | View |
| 2021-06-11 Tax Withholding | 2021-06-14 6:21 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 37,800 | $4.45 | 758,394 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:21 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 25,452 | $4.42 | 298,400 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:21 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 48,542 | $0 | 298,400 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:20 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 248,869 | $4.42 | 2,871,259 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 6:20 pm | N/A 2031-06-10 | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 474,629 | $0 | 2,871,259 (Direct) | View |
| 2021-06-11 Tax Withholding | 2021-06-14 6:20 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 99,209 | $4.45 | 2,871,259 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-10 5:39 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | Powell Fred M Executive Vice President & CFO | 12,045 | $4.39 | 704,886 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-10 5:38 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GRAHAM PETER J EVP General Counsel, Secretary | 15,996 | $4.39 | 546,258 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-10 5:37 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | APPLE ROBERT F President & CEO | 44,223 | $4.39 | 2,246,970 (Direct) | View |
| 2021-05-04 Exercise | 2021-05-06 4:53 pm | N/A 2021-05-16 | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 40,000 | $0 | 542,125 (Direct) | View |
| 2021-05-04 Exercise | 2021-05-06 4:53 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 40,000 | $1.66 | 542,125 (Direct) | View |
| 2021-04-29 Exercise | 2021-05-03 5:56 pm | N/A 2021-05-16 | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 72,669 | $0 | 502,125 (Direct) | View |
| 2021-04-29 Exercise | 2021-05-03 5:56 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GUETH ANTON Director | 72,669 | $1.66 | 502,125 (Direct) | View |
| 2021-04-26 Option Award | 2021-04-28 8:40 pm | N/A 2031-04-26 | ANTARES PHARMA INC. | ATRS | Richardson Peter C EVP, R&D Chief Medical Officer | 59,179 | $0 | 59,179 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-12 7:04 pm | N/A 2026-06-02 | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 50,000 | $0 | 224,406 (Direct) | View |
| 2021-03-11 Exercise | 2021-03-12 7:04 pm | N/A N/A | ANTARES PHARMA INC. | ATRS | GARRITY THOMAS J Director | 50,000 | $1.12 | 224,406 (Direct) | View |